Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial
Ritesh Patil, Guy T. Clifton, Jarrod P. Holmes, Asna Amin, Mark G. Carmichael, Jeremy D. Gates, Linda H. Benavides, Matthew T. Hueman, Sathibalan Ponniah, George E. Peoples
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Clinical and Immunologic Responses of HLA-A3+ Breast Cancer Patients Vaccinated with the HER2/neu-Derived Peptide Vaccine, E75, in a Phase I/II Clinical Trial'. Together they form a unique fingerprint.